Merck
Worldwide
   
En español

 



Be a Part of a Study

Thank you for your interest in this investigational study.

As new sites start enrolling, they will be added to the interactive map. You will see contact information on the map for each site.

You may also call Telerx for more information at 888-577-8839. Please reference study ID number 2007_508 or 2007_507.

This study has been registered on www.ClinicalTrials.gov under identifiers NCT00443729 (Canada, Denmark, Germany, Italy, Netherlands, Portugal, Spain, United Kingdom, United States) or  NCT00443703 (Australia, Brazil, Colombia, India, Mexico, Peru, South Africa, Thailand, United States).

BENCHMRK ExPI
More about
 
You may be eligible for the study if you:

AGES: 18 years and older
GENDER:  male and female

Inclusion Criteria:

  • Are HIV positive with a viral load <50 copies/mL
  • Are currently receiving HIV treatment that includes a protease inhibitor
  • Are not currently on any lipid lowering treatment

Copyright © 2005-2007 Merck & Co., Inc., All rights reserved.

Contact Merck Privacy Policy Terms of Use Copyright Merck & CO., Inc. (USA)